Leukemogenic nucleophosmin mutation disrupts the transcription factor hub that regulates granulomonocytic fatesXiaorong Gu, Yogen Saunthararajah|Journal of Clinical Investigation|2018Cited by 117
Effects of tetrahydrouridine on pharmacokinetics and pharmacodynamics of oral decitabineDonald Lavelle, Yogen Saunthararajah|Blood|2011Cited by 100
GATA4 loss of function in liver cancer impedes precursor to hepatocyte transitionFrancis Enane, Yogen Saunthararajah|Journal of Clinical Investigation|2017Cited by 49
Noncytotoxic Differentiation Treatment of Renal Cell CancerSoledad Negrotto, Yogen Saunthararajah|Cancer Research|2011Cited by 33
DNA Methyltransferase 1 Targeting Using Guadecitabine Inhibits Prostate Cancer Growth by an Apoptosis-Independent PathwayDev Karan, Yogen Saunthararajah|Cancers|2023Cited by 9